NAD+ and Cellular Health: What Longevity Researchers Are Actually Studying

If you follow longevity research at all, you've probably encountered NAD+. It appears in conversations about aging at Harvard Medical School, in the research of scientists like David Sinclair, and increasingly in the practices of physicians focused on healthspan optimization.

But what exactly is NAD+, why do researchers find it so compelling, and what does physician-supervised supplementation actually look like? Here's an educational overview.

What Is NAD+?

NAD+ stands for nicotinamide adenine dinucleotide — a coenzyme found in every living cell in your body. It plays a fundamental role in two of biology's most essential processes:

• Energy metabolism: NAD+ is required for the conversion of nutrients into ATP — the molecule cells use for energy. Without adequate NAD+, cellular energy production becomes compromised.
• DNA repair and cellular maintenance: NAD+ is consumed by several classes of enzymes, including sirtuins and PARPs, that are involved in DNA repair, stress response, and cellular quality control.

In short, NAD+ is not a fringe wellness compound. It is a molecule that sits at the intersection of cellular energy and cellular repair — two processes that are central to how we age.

The NAD+ Decline Problem

Here is the finding that drives much of the research interest: NAD+ levels decline significantly with age. Some estimates suggest levels may fall by as much as 50% between young adulthood and middle age, with the decline continuing thereafter.

This decline has been documented in multiple tissues, including muscle, liver, and brain tissue. Researchers studying aging-related dysfunction have proposed that declining NAD+ levels may contribute to several hallmarks of aging, including:

• Reduced cellular energy production and mitochondrial dysfunction
• Impaired DNA repair capacity
• Dysregulation of sirtuin activity — enzymes that play roles in cellular stress response and longevity pathways
• Increased cellular senescence (the accumulation of dysfunctional "zombie cells")

The logical question that follows: can restoring or maintaining NAD+ levels reverse or slow some of these aging-related changes?

What the Research Has Examined

NAD+ precursors — compounds that the body uses to synthesize NAD+ — have been the subject of numerous human clinical trials over the past decade. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) in particular have been studied for their ability to raise NAD+ levels in humans.

Published research has examined effects on:

• Skeletal muscle NAD+ levels and mitochondrial function in older adults
• Metabolic health markers including insulin sensitivity
• Cardiovascular function and blood pressure
• Cognitive function and brain health markers
• Physical performance and muscle strength in older populations

Results have been mixed — some trials show meaningful improvements in specific markers, others show modest or no effects on the endpoints measured. The field is genuinely still developing, and translating preclinical (animal) findings to consistent human outcomes has proven challenging, as is common in longevity science.

Why Injectable NAD+ Is Different

Most consumer NAD+ products are oral — capsules or sublingual formulations. Injectable NAD+, by contrast, bypasses the digestive system entirely and delivers the compound directly into circulation.

The theoretical advantage of injectable delivery is bioavailability — avoiding first-pass metabolism and ensuring the compound reaches target tissues. In practice, whether this translates to meaningfully different clinical outcomes compared to oral precursors is an area of active investigation.

Injectable NAD+ administration requires physician evaluation and prescription, which is appropriate given that it's an IV or subcutaneous injection that bypasses normal metabolic pathways. It is not a supplement someone should self-administer without medical oversight.

Who Is Interested in NAD+ Therapy?

The people most interested in physician-supervised NAD+ therapy tend to fall into a few categories. High-performance individuals — athletes, executives, people with demanding physical or cognitive workloads — who are focused on recovery and sustained energy. People in midlife who are proactively investing in longevity and want physician oversight rather than self-experimenting with supplements. And people already working with a physician on a broader optimization protocol who are adding NAD+ as one component of a comprehensive approach.

It is not typically the first intervention a longevity-focused physician recommends — fundamentals like sleep, resistance training, nutrition, and metabolic health generally come first. NAD+ therapy tends to be part of a more comprehensive stack, not a standalone solution.

The Bottom Line

NAD+ occupies an interesting position in longevity science — there is legitimate mechanistic rationale for why it matters, a growing body of human research, and strong interest from serious researchers at major institutions. At the same time, many questions remain about optimal delivery, dosing, and which populations benefit most.

What is clear is that physician oversight matters here. NAD+ injections are medical interventions, not supplements, and should be treated accordingly.